Twist Bioscience Corp (TWST) financials

Twist Bioscience Corp (TWST) revenue, EBIT and EBITDA, earnings per share, free cash flow, margins, debt and shareholders equity — annual and quarterly history, charted from SEC filings. No account needed.

In fiscal 2025, Twist Bioscience Corp reported revenue of $377M, up 20.3% year over year, net income of -$78M, diluted EPS of -$1.30 and free cash flow of -$76M.

Revenue (fiscal 2025)

$377M

Revenue growth (fiscal 2025)

20.3%

Net income (fiscal 2025)

-$78M

Diluted EPS (fiscal 2025)

-$1.30

Free cash flow (fiscal 2025)

-$76M

Twist Bioscience Corp files with the U.S. Securities and Exchange Commission under CIK 0001581280, classified as Biological Products, (No Diagnostic Substances).

Explore annual and quarterly revenue, earnings, cash flow, margins, debt and equity from SEC filings.